Wikipedia:WikiProject Medicine/Newsletter/March 2021

Issue 10—March 2021

WikiProject Medicine Newsletter

Here is what's happening around the project:

Newly recognized content

17q12 microdeletion syndrome nom. Vaticidalprophet, reviewed by Bibeyjj Urinothorax nom. Steve M., reviewed by Bibeyjj Lurie Children's Hospital nom. Andrew nyr, reviewed by HickoryOughtShirt?4 Biotin nom. David notMD, reviewed by HaEr48 Imprinted brain hypothesis nom. Vaticidalprophet, reviewed by Lee Vilenski

Nominated for review

Friedreich's ataxia nom. Akrasia25 Kivu Ebola epidemic nom. Ozzie10aaaa, under review by Casliber Diaphragmatic rupture nom. Steve M. Mihran Kassabian nom. Larry Hockett Sophie Jamal nom. Vaticidalprophet Menstrual cycle Undergoing FAR, contribute at talk. Alzheimer's disease Notice of impending FAR at talk. Major depressive disorder Notice of impending FAR at talk. Acute myeloid leukemia Notice of impending FAR at talk. Influenza Notice of impending FAR at talk. Autism Notice of impending FAR at talk.

News from around the site

• There is an ongoing drive to review good article nominations through the month of March. Pick up a review if you have time. Instructions here.
• The Medicine Collaboration of the Month is on temporary (perhaps) hiatus. You can still nominate future candidates at WP:MCOTM.
• This month's target maintenance backlog is "articles with a dead link". Each typically takes around a minute to fix, so please hit one or two when you have a moment.
• The desktop site's default "Vector" skin is being gradually modernized. Details here. Opt-in at Preferences>Skin preferences to begin getting used to the new look.

Discussions of interest

• A large discussion is reconsidering deprecating the aliases for some citation template parameters.
• Please look over edit-protected medicine pages to consider whether some could have protection levels safely lowered.

Discuss this issue

You are receiving this because you added your name to the WikiProject Medicine mailing list. If you no longer wish to receive the newsletter, please remove your name.